Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR
Citations Over TimeTop 1% of 2025 papers
Abstract
ABSTRACT The tumor microenvironment (TME) is a critical factor in antitumor immunity and treatment outcome in cancer therapy. We have developed an analysis tool called the immuno‐oncology biological research (IOBR) to investigate the TME and its role in antitumor immunity. Leveraging multi‐omics data, IOBR facilitates comprehensive analysis of TME characteristics, immune interactions, and their impact on immunotherapy outcomes. IOBR features six modules for TME analysis, including transcriptomic data preprocessing, TME profiling, TME pattern identification, ligand–receptor interaction analysis, genome‐TME interaction assessment, and visualization, along with modeling. Since its release, this tool has been widely applied in many studies. In the future, IOBR will gradually integrate TCR/BCR repertoire analysis, enhance genomic functionalities, and develop spatial transcriptomics modules, which will further our understanding of TME dynamics and tumor immunity.
Related Papers
- → EFFECT OF THE NEMATODE PHASMARHABDITIS HERMAPHRODITA ON YOUNGSTAGES OF THE PEST SLUG ARION LUSITANICUS(2002)40 cited
- → Cloning and Characterization of Rat BAT3 cDNA(1999)20 cited
- → Anthoxanthum Mosaic Virus(1970)6 cited
- → HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53(2007)127 cited
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)